BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Chiron Corporation (CHIR) FLUVIRIN Vaccine License Reinstated By UK Regulatory Agency


10/19/2005 5:12:53 PM

EMERYVILLE, Calif.--(BUSINESS WIRE)--March 2, 2005-- Chiron Corporation (Nasdaq:CHIR) today announced that it has received notice from the UK Medicines and Healthcare products Regulatory Agency (MHRA) that the agency has lifted the license suspension for Chiron's Liverpool manufacturing facility, which produces FLUVIRIN(R) influenza virus vaccine. The notice, which follows MHRA inspections of the Liverpool facility, states that "it is the opinion of the Licensing Authority that (Chiron is) now in a position to conduct (its) operations in accordance with the principles and guidelines of Good Manufacturing Practices (GMP)." The decision is conditioned on the understanding that Chiron's high level of commitment to the completion of its remediation plan and ongoing improvements will continue. Chiron will provide the MHRA with regular weekly updates to ensure that progress on its various projects proceeds satisfactorily, and the MHRA may conduct further inspections. Chiron now has clearance to initiate full production of FLUVIRIN vaccine.

Read at BBC News
Read at AP
Read at BioSpace.com
Read at Market Watch

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->